Arbutus Biopharma Corp (ABUS) ticks all the boxes for top investors with its surprise performance of 2.79% last month.
On Tuesday, Arbutus Biopharma Corp (NASDAQ: ABUS) opened lower -5.41% from the last session, before settling in for the closing price of $3.51. Price fluctuations